PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.\', \'Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.\', \'Department of Infectious Diseases, University Hospital, LMU Munich, Munich, Germany.\', \'Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany.\', \'German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.\', \'Faculty of Business Administration and Economics, Bielefeld University, Bielefeld, Germany.\', \'Center for Mathematics, Technische Universität München, Garching, Germany.\', \'Center for International Health (CIH), University Hospital, LMU Munich, Munich, Germany.\', \'German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.\', \'Unit for Clinical Pharmacology (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.688436
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34093595
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all